Department of Psychiatry
Penn Behavioral Health

HIV/AIDS Prevention Research Division

subpage feature

Current Studies





Recruitment Complete

HVTN 070 - A Phase I study to evaluate the safety of a new, experimental HIV vaccine known as PENNVAX developed at the University of Pennsylvania. This is the first time this vaccination is being given to humans. (For more information, click here.)

HVTN 504 - A rollover observational study for STEP (HVTN 502) study participants.

HVTN 906 - An observational study of women at high risk of becoming HIV infected. (For more information, click here.)

HVTN 080 - A Phase I study to evaluate the safety of a new, experimental HIV vaccine developed at the University of Pennsylvania known as PENNVAX (same product as HVTN 070). The vaccine will be administered in this study with a novel technique known as electroporation.




Open Recruitment

HVTN 505 - A study of an experimental HIV vaccine in circumcised men who have sex with men. (For more information, click here.)





Future Studies

 

 

 


 


Connect with us twitter

Contact Us arrow

To make an appointment, or inquire further about our services, please call: 1-866-448-7366.

Click here for directions and contact information.